Alzheimer's disease is a common neurodegenerative symptom whose effects on the brain are being intensively researched.

Biomarkers are being used to monitor the progression of the disease and understand the patient's experience. You’ll listen to a discussion on current detection capabilities, the use of biomarkers for disease monitoring and ongoing Alzheimer's research and you will gain insights into the progression and treatment of the disease.

Lance Ladic, Siemens Healthineers’ Director of Strategic Innovation is joined by three guests - Tammie Benzinger, Professor of Radiology at the Mallinckrodt Institute in St. Louis at Washington University, Dr. Anne Börjesson-Hanson, Director of Clinical Trials at the Department for Aging at Kalinsky University Hospital, and Duygu Tosun-Turgut, Associate Professor at the University of California San Francisco in the Department of Radiology and Biomedical Imaging.

00:00 How Can we spot the early signs of dementia?
01:09 Introduction to the episode
09:46 Understanding dementia
14:32 Understanding comorbidities
19:20 The future of Alzheimer's disease detection and monitoring
23:55 Conclusion